Questions on health
Frequently asked Questions on Health topic
Can person on psychiatric medicine go for corona vaccine?
Ans- Psychiatric medication and corona vaccine:
Even though the term “severe mental illness” is most commonly used to describe schizophrenia, bipolar disorder, and major depressive disorder, it can be further broadly applied to any mental illness, that causes severe functional impairment.
As per World Mental Health Survey, the prevalence of serious mental disorders is likely to be between 0·4% and 7·7%.
Though, how the pandemic affects the prevalence of psychiatric disorders is still uncertain.
Psychiatric disorders, and particularly severe mental illness, are associated with bigger risk of severe acute respiratory syndrome, corona-virus infection and COVID-19-related morbidity and death.
Persons with severe mental illness have a two to three times high mortality rate than general population.
Possibly, the increased risk of worse COVID-19-related outcomes in patients with psychiatric disorders, and mainly in those with severe mental illness, is due to frequent co morbidity with physical diseases associated to poor COVID-19 outcomes.
Psychiatric disorders give an additional risk for SARS-CoV-2 infection and COVID-19-related morbidity and mortality.
Patient with severe mental illness will already be covered by vaccine distribution strategies because of their physical health status.
Severe mental illness is related with altered immune function,
Chronic stress, which has an important role in the beginning of severe and impairing psychiatric disorders, is another factor that impairs immune systems.
Sleep problems, which are common in many psychiatric disorders and often serious in severe mental illness, are also frequently associated with compromised immune system and increased risk of acute infection.
In addition social exclusion and loneliness are associated with increased inflammation and decreased anti-viral immunity, which suggests another link between severe mental illness and the immune system.
These immunological alterations can prompt people with severe mental illness to a more severe SARS-CoV-2 infection.
Compared with the general population, patients with severe mental illness are more likely to be obese or have physical diseases, such as cardiovascular diseases, type 2 diabetes, and respiratory tract diseases, all risk factors for worse COVID-19-related outcomes.
Patients with severe mental illness should therefore be prioritized in vaccine allocation strategies.
Patients with severe mental illness should be given priority because they are a deprived group based on both medical and socio-economic risk factors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, morbidity, and mortality.
Since people with severe mental illness are at high risk for SARS-CoV-2 infection and COVID-19-related morbidity and mortality, they must be accessible early access to safe and efficacious vaccines.
As a result, patients with severe mental illness have been specifically recognized by some ethical guidelines as a high-risk group.
Upcoming studies should assess vaccine efficacy, safety, and interactions with psychotropic medication. Specifically in people with severe mental illness so they can be properly informed of the benefits and risks of vaccination.
Common questions on Health topic: FAQ about Mental Health
Q. No. 2
Is use of Remedesivir suitable for people who have undergone kidney transplant and have been affected with Corona virus ?
With respect to Remdesivir and its metabolite GS-441524, there are no human data to declare its safety in patients with impaired renal function because they were excluded from the clinical trials.
It should be emphasized that, in repeat-dose toxicity studies in rats and monkeys, the kidney (i.e., tubular epithelium) was recognized as the primary target organ of Remdesivir toxicity.
Clinicians discourage Remdesivir as routine treatment in patients with COVID-19 and CKD (eGFR of <30 ml/min per 1.73 m3).
Its use should be detained in reserve, to the context of clinical trials to advance knowledge regarding safety and efficacy.
A recent pharmacokinetic study showed elevated metabolite GS-441524 levels in a patient with renal dysfunction.
As far as patient with covid-19, having dialysis is concerned, primary metabolite of Remdesivir, GS-441524 will be removed by hemodialysis,
Toxicity of Remdesivir or its metabolite will not be an issue in patients who are already on hemodialysis but it should be purely clinical decision considering all other parameters.
Motivational Quotes on mental health during lockdown ?
“At such a stressful time, students need reassurance more than ever, and this need has not been adequately met “.
“We are in this together and we will get through this, together.”
“Caring for others is important, but Covid-19 taught us that sometimes, by caring for yourself, you are caring for others also”
Physical distancing is going to be our reality for the foreseeable future. So give yourself-and your days some structure, even if you are not going any where.”
“Taking care of youeself does not mean me first, it means me too.”
For more interesting health phrases please visit…https://nirajhealth.com/15-proverbs-on-mental-and-physical-health/
Top 5 Best and Worst countries who manage the corona cases ?
|Best Countries||Worst countries|
(Position might be change)
Which countries has good and poor mental health conditions ?
Ans- Mental health conditions